MYL2 and metabolic syndrome: Similarly, we identified that the risk-specific allele, MYL2 rs3782889, correlates with a decreased odds ratio (OR) of MetS (OR = 0.91, P = 0.02), suggesting that this locus might reduce MetS susceptibility, via increasing HDLc, and lowering TG levels.